The State of AI in Precision Oncology 2025
The State of AI in Precision Oncology 2025 is the third annual, free virtual summit hosted by the journal AI in Precision Oncology, aiming to assess the current evolution of […]
The State of AI in Precision Oncology 2025 is the third annual, free virtual summit hosted by the journal AI in Precision Oncology, aiming to assess the current evolution of […]
The EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC is scheduled for December 17, 2025, at 18:00 CET. This free, open-to-all online event will feature experts from medical oncology, radiation oncology, and thoracic surgery who will explore and discuss the status of current as well as upcoming clinical trials focused […]
The SITC Webinar on Bispecifics and T cell Engagers: Practical Strategies for Recognizing and Managing Toxicities is a virtual, multi-stakeholder event scheduled for December 17, 2025, from 1:00 p.m. to […]
"Going Full TILt: challenges, successes, and coordination with administering TIL therapy" is an upcoming "Rx-cited: Clinical Conundrums" roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task […]
The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10, 2026, at Moscone West in San Francisco, CA, as well as online. This annual event gathers oncology professionals from around the world to explore the latest developments in GI cancer treatment, research, and patient care. Featuring cutting-edge scientific presentations and multidisciplinary discussions, the […]
The Highlights of ASH in North America is a two-day program offered by the American Society of Hematology (ASH) in multiple locations to explore and discuss the most influential and novel research presented at the latest ASH Annual Meeting. The program is designed to allow hematology leaders and experts to connect in person, learn how […]
The MASCC Webinar “ADCs and Mucositis: From Mechanism to Care” on January 15, 2026, at 8:00 PM UTC+4 will explore the therapeutic potential and toxicity of antibody-drug conjugates (ADCs), with a focus on the recognition, prevention, and management of ADC-induced oral mucositis. Expert speakers, including Prof. Paolo Bossi, Prof. Florian Scotté, Dr. Barbara Pistilli, Dr. […]
The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management, covering topics from diagnosis to treatment, based on current standards of care in a multidisciplinary setting. The preceptorship will take place from January 16–17, 2026, in Milan, Italy. The course is […]
The Cancer Immunotherapy Winter School, hosted by the Society for Immunotherapy of Cancer (SITC), is a hybrid program taking place in Boston and virtually from February 16–18, 2026, with the in-person meeting held at The Westin Copley Place, Boston. The school is tailored for early-to-mid career scientists and clinicians who are new to the field, […]
The 22nd Oncology Updates: Advanced and Controversies Conference, presented by The University of Texas MD Anderson Cancer Center, is an interactive, multidisciplinary forum held from Friday, January 16 to Monday, January 19, 2026, at the Steamboat Grand Hotel in Steamboat Springs, Colorado. The conference is designed to address the rapidly evolving complexities of solid tumor […]
The 2nd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care will be held from January 16 to 18, 2026, in Hollywood, Florida. This premier event brings together a diverse range of oncology professionals including medical oncologists, hematologists, radiation oncologists, and other healthcare providers to explore the latest developments in cancer diagnosis, treatment, and supportive […]
The European Association for Cancer Research (EACR) conference, "Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy," is a Virtual Event scheduled for January 20-21, 2026. This conference explores a paradoxical and radically different approach to cancer therapy: instead of inhibiting the signals that drive cancer, it focuses on the deliberate hyper-activation of oncogenic […]